PubMed Health⌕ Search

Biomedical subjects

A Glessa

Publications and source records attributed to A Glessa.

3 recordsLinked to original sources

A single prophylactic antibiotic for emergency appendicectomy?

This paper reports the results of a prospective randomized study of antibiotic prophylaxis in 200 patients over the age of 12 years undergoing emergency appendicectomy at Al-Jala Hospital for Trauma and Emergency Surgery, Benghazi. We have compared the efficacy of ceftriaxone, a long-acting broad-spectrum cephalosporin with that of our routine regimen consisting of metronidazole, gentamicin and ampicillin, given together. Ceftriaxone was administered as a single pre-operative dose of 2 g (to be continued as a daily injection for 5 days in patients with perforated appendicitis). The triple combination was given on an 8-hourly basis for 3 days, extended to 5-7 days in cases of perforation. Patients receiving ceftriaxone did as well as or slightly better than those on the triple-antimicrobial regimen, in terms of wound infection rate (3 vs. 5%), incidence of transient post-operative pyrexia and duration of hospital stay (on average 4.5 vs. 5.9 days). More importantly, administering ceftriaxone as 1 injection per day led to a dramatic saving in terms of nursing effort and time (1 injection instead of 9 per 24 h) and of the daily financial cost of therapy per patient. It is concluded that the clinical results and economic implications seem to justify the use of ceftriaxone as a routine prophylactic antibiotic for patients undergoing emergency appendicectomy.

Adolescent↗

Ceftriaxone versus clavulanate-potentiated amoxycillin for prophylaxis against post-operative sepsis in biliary surgery: a prospective randomized study in 200 patients.

A prospective study was carried out in 200 consecutive patients undergoing biliary surgery to compare the prophylactic effectiveness of ceftriaxone and clavulanate-potentiated (CP-) amoxycillin. Patients were assigned in a randomized fashion to two groups and received ceftriaxone (2 g intravenously pre-operatively), or CP-amoxycillin (1200 mg, to be repeated for 2 more doses in the case of patients undergoing procedures other than elective cholecystectomy). Post-operative wound infection occurred in 4% of patients in each group. Administration of ceftriaxone was associated with a lower incidence of post-operative pyrexia and chest infection as well as with a shorter hospital stay.

Adult↗

Single-dose clavulanate-potentiated amoxycillin versus three-dose cefotaxime in the prevention of wound infection following elective cholecystectomy: a prospective randomized study.

A prospective randomized study was carried out to evaluate the efficacy of clavulanate-potentiated amoxycillin with that of cefotaxime as prophylactic agents for the prevention of sepsis following elective cholecystectomy. One hundred patients were randomized into two treatment groups. In the first group, each patient received a single intravenous dose (1200 mg) of clavulanate-potentiated amoxycillin 2 h before surgery. In the second group, patients were given intravenous cefotaxime, in three doses (2 g each) during surgery, and 6 and 12 h after their operation. No case of serious post-operative sepsis occurred in either group. Superficial wound infection occurred in 2% of patients receiving a single pre-operative dose of clavulanate-potentiated amoxycillin and in 6% of those given cefotaxime according to the three-dose regimen.

Amoxicillin↗